Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy

BACKGROUND: Lamivudine monotherapy is effective in suppressing hepatitis B virus (HBV) replication to undetectable levels by PCR, in ameliorating liver disease and to some extent in achieving HBsAg seroconversion. This study aimed at assessing the virological and biochemical responses as well as bre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Sohair, Hafez, Hanan Abdel, Darweesh, Samar K., Kamal, Kamal Hassan, Esmat, Gamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188937/
https://www.ncbi.nlm.nih.gov/pubmed/25331321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188937/
https://www.ncbi.nlm.nih.gov/pubmed/25331321

Ejemplares similares